Fig. 1: Thrombosis rate in conventional thrombotic risk groups.
From: QRISK3 score is predictive of thrombotic risk in patients with myeloproliferative neoplasms
A, B Incidence of thrombosis in ET and PV patients, occurring in conventional high-risk (HR) and low-risk (LR) groups.
